Literature DB >> 7648404

Localization of dihydroorotate oxidase in myocardium and kidney cortex of the rat. An electron microscopic study using the cerium technique.

S Angermüller1, M Löffler.   

Abstract

Biochemical studies have demonstrated that dihydroorotate dehydrogenase (DHOdehase; EC 1.3.3.1 or 1.3.99.11) is the sole enzyme of de novo pyrimidine synthesis in mitochondria, whereas the rest of the pathway takes place in the cytosol. The dehydrogenation of dihydroorotate to orotate is linked to the respiratory chain via ubiquinone. In this study, we show for the first time the ultrastructural localization of DHOdehase. Since the purified enzyme was found to act both as dehydrogenase and as oxidase, the cerium capture technique for detecting enzymatically generated hydrogen peroxide could be applied to pin-point the in situ activity of DHOdehase oxidase in mitochondria of rat heart and kidney cortex. Cerium perhydroxide as the final reaction product was detected predominantly in the matrix with some focal condensation along the inner membrane, but not in the intermembrane space. From this pattern of localization, it is concluded that the active site of the membrane-bound enzyme could face the mitochondrial matrix similar to succinate dehydrogenase. The reliability of the applied method for the demonstration of DHOdehase oxidase was demonstrated by the addition of Brequinar sodium to the incubation medium. This quinoline-carboxylic acid derivative is a potent inhibitor of DHOdehase and has proven anti-proliferative activity. The present observations do not ascertain whether the oxidase is permanently active as a constant portion of the enzyme in vivo, similar to xanthine oxidase/dehydrogenase. However, DHOdehase should be considered as a source of radical oxygen species under pathophysiological conditions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7648404     DOI: 10.1007/bf01457413

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  24 in total

1.  Histochemical demonstration of a dihydroorotate dehydrogenase system in tissues.

Authors:  R B COHEN
Journal:  Lab Invest       Date:  1962-07       Impact factor: 5.662

2.  Inhibition of pyrimidine de novo synthesis by DUP-785 (NSC 368390).

Authors:  G J Peters; S L Sharma; E Laurensse; H M Pinedo
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

3.  The "anti-pyrimidine effect" of hypoxia and brequinar sodium (NSC 368390) is of consequence for tumor cell growth.

Authors:  M Löffler
Journal:  Biochem Pharmacol       Date:  1992-05-28       Impact factor: 5.858

4.  Localization of xanthine oxidase in crystalline cores of peroxisomes. A cytochemical and biochemical study.

Authors:  S Angermüller; G Bruder; A Völkl; H Wesch; H D Fahimi
Journal:  Eur J Cell Biol       Date:  1987-12       Impact factor: 4.492

5.  Mammalian dehydroorotate-ubiquinone reductase complex.

Authors:  R W Miller; C T Kerr; J R Curry
Journal:  Can J Biochem       Date:  1968-09

Review 6.  Xanthine oxidase: biochemistry, distribution and physiology.

Authors:  D A Parks; D N Granger
Journal:  Acta Physiol Scand Suppl       Date:  1986

7.  On the role of dihydroorotate dehydrogenase in growth cessation of Ehrlich ascites tumor cells cultured under oxygen deficiency.

Authors:  M Löffler
Journal:  Eur J Biochem       Date:  1980

8.  Possible mode of action of toltrazuril: studies on two Eimeria species and mammalian and Ascaris suum enzymes.

Authors:  A Harder; A Haberkorn
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

9.  Heterogenous staining of D-amino acid oxidase in peroxisomes of rat liver and kidney. A light and electron microscopic study.

Authors:  S Angermüller; H D Fahimi
Journal:  Histochemistry       Date:  1988

10.  Differential susceptibility of dihydroorotate dehydrogenase/oxidase to Brequinar Sodium (NSC 368 390) in vitro.

Authors:  G Lakaschus; M Löffler
Journal:  Biochem Pharmacol       Date:  1992-03-03       Impact factor: 5.858

View more
  5 in total

1.  Dihydroorotat-ubiquinone oxidoreductase links mitochondria in the biosynthesis of pyrimidine nucleotides.

Authors:  M Löffler; J Jöckel; G Schuster; C Becker
Journal:  Mol Cell Biochem       Date:  1997-09       Impact factor: 3.396

2.  Teriflunomide (leflunomide) promotes cytostatic, antioxidant, and apoptotic effects in transformed prostate epithelial cells: evidence supporting a role for teriflunomide in prostate cancer chemoprevention.

Authors:  Numsen Hail; Ping Chen; Lane R Bushman
Journal:  Neoplasia       Date:  2010-06       Impact factor: 5.715

3.  Catalytic enzyme histochemistry and biochemical analysis of dihydroorotate dehydrogenase/oxidase and succinate dehydrogenase in mammalian tissues, cells and mitochondria.

Authors:  M Löffler; C Becker; E Wegerle; G Schuster
Journal:  Histochem Cell Biol       Date:  1996-02       Impact factor: 4.304

4.  Purification and characterization of dihydroorotate dehydrogenase A from Lactococcus lactis, crystallization and preliminary X-ray diffraction studies of the enzyme.

Authors:  F S Nielsen; P Rowland; S Larsen; K F Jensen
Journal:  Protein Sci       Date:  1996-05       Impact factor: 6.725

5.  Multi-focal control of mitochondrial gene expression by oncogenic MYC provides potential therapeutic targets in cancer.

Authors:  Amanda R Oran; Clare M Adams; Xiao-Yong Zhang; Victoria J Gennaro; Harla K Pfeiffer; Hestia S Mellert; Hans E Seidel; Kirsten Mascioli; Jordan Kaplan; Mahmoud R Gaballa; Chen Shen; Isidore Rigoutsos; Michael P King; Justin L Cotney; Jamie J Arnold; Suresh D Sharma; Ubaldo E Martinez-Outschoorn; Christopher R Vakoc; Lewis A Chodosh; James E Thompson; James E Bradner; Craig E Cameron; Gerald S Shadel; Christine M Eischen; Steven B McMahon
Journal:  Oncotarget       Date:  2016-11-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.